The efficacy of quazepam (Sch-16134) 15 mg capsules as a hypnotic has been compared with that of placebo in a 9-day study, using a parallel-group design. The physician's global evaluation numerically favoured quazepam 63% (nineteen of thirty) over placebo 50% (fifteen of thirty). Furthermore, it demonstrated greater improvement in Hypnotic Activity Index and Sleep Quality Index from baseline scores, and caused no adverse reactions.
Get full access to this article
View all access options for this article.
References
1.
MamelakMCsimaAPriceV (1981) The effects of quazepam on the sleep of chronic insomniacs. Current Therapeutic Research29, 135.
2.
RothTTietzEKramerMKaffemanM (1979) The effect of a single dose of quazepam (Sch-16134) on the sleep of chronic insomniacs. Journal of International Medical Research7, 583.
3.
Schering Corporation Report (1979) The pharmacokinetics of 15C-Quazepam (Schering 16134) in man.
4.
VogelG WAnsleyKMcDanielBThurmondARabinowitzP (1980) The effect of three doses of quazepam (15, 30, 45 mg) on subjective and polygraphic measures of insomnia. 20th Association for the Psycho-Physiological Study of Sleep Meeting Mexico. p 249.
